An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Several professionals stated the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and customer laws, risking fines, legal action or imprisonment.
Service Reaction and Content Elimination
According to TikTok, the platform has removed problematic material and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, populated with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
Within moments of entering one group, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.
Product Information and Costs
Inside these groups, posts display black plastic parcels with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her team has previously seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to potentially significant medical dangers”.
